The Knight Cancer Institute at Portland-based Oregon Health & Science University and the Oregon Health Authority have partnered on the “2025 Comprehensive Cancer Control Plan,” a statewide strategy to reduce the burden of cancer.
The organizations identified five priority areas of focus: liver, breast, colorectal and lung cancers, and increasing HPV vaccination rates, according to a Feb. 20 news release from the university.
The Knight Cancer Institute will use the priorities to “drive its scientific strategic planning,” the release said.
The institute recently appointed Joel Helmke as CEO of the Knight Cancer Group. The Knight Cancer Group — established through a $2 billion donation from Phil and Penny Knight — governs the Knight Cancer Institute’s care model and manages OHSU’s cancer services.
OHSU will open the Vista Pavilion, a $650 million cancer center, on April 7.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
